Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. by Mitchell Hayes (5334887)

Loss of C1-FDX results in a reduction of the CI and CV activity. by Baoyin Chen (2635399)

The presence of the gRNA targeting <i>OPG147</i> has no effect on transcription of viral entry and early genes. by Xue-Mei Yi (18851202)

The regulation of LGG supplementation of the adaptive immune triggered by <i>M</i>. <i>pneumoniae</i>. by Huanbing Long (19949784)

Supplementation of five Lactobacillus strains affected the colonization of <i>M</i>. <i>pneumoniae</i> and lung injuries. by Huanbing Long (19949784)

Both live and heat-inactivated LGG supplementation attenuated lung tissue injury caused by <i>M</i>. <i>pneumoniae</i> infection. by Huanbing Long (19949784)

Supplementation with LGG effectively influenced the recruitment of innate immune cells following <i>M</i>. <i>pneumoniae</i> infection. by Huanbing Long (19949784)

Data for Figs 8A–8H, 9A–9K, 10A–10I. by Xiaohua Zhang (350570)

“…In <i>vivo</i> experiments further showed that PRV UL4 (¹³²DVAADAAAEAAAAE¹⁴⁵) mutated strain (PRV-UL4^mut) infection did not lead to a significant decrease in viral titers at 12 h. p. i, but it induced lower levels of IL-1β, IL-18, and GSDMD-NT, which led to an alleviated inflammatory infiltration and pathological damage in the lungs and brains, and a lower death rate compared with wild-type PRV strain infection. …”

Mutation of vOPG147 F55, T116 and T117 does not affect replication and production of VACV. by Xue-Mei Yi (18851202)

vOPG147-deficiency promotes innate immune response to VACV. by Xue-Mei Yi (18851202)

OPG147 is associated with MITA. by Xue-Mei Yi (18851202)

OPG147-deficiency promotes innate immune response to MPXV. by Xue-Mei Yi (18851202)

OPG147 contributes to VACV evasion of host defense and is a virulence factor <i>in vivo.</i> by Xue-Mei Yi (18851202)

(A) Appearance image of psoriasis on the back skin of mouse. by Xiaoqiang Huang (1457860)

Anthropometric, nutritional, and variable assessments of lean mass and fat mass obtained by DXA of exclusive breastfeeding mothers (EBF), at pre-pregnancy, baseline (15 days), and... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Comparisons between densitometric, biochemical, and hormonal variables and bone remodeling markers of exclusive breastfeeding mothers (EBF) 15 days postpartum and the same EBF moth... by Larissa Brazolotto Ferreira (17671168)

Subjects:

Flowchart of the exclusive breastfeeding mothers (EBF) and the exclusive breastfeeding mother-donors (EBF+) who participated in the study. by Larissa Brazolotto Ferreira (17671168)

Subjects:

Timeline of monitoring of exclusive breastfeeding mothers (EBF) and exclusive breastfeeding – donors (EBF+). by Larissa Brazolotto Ferreira (17671168)

Subjects:

Comparison of densitometric, biochemical, and hormonal variables, and bone turnover markers of EBF + 6 months versus EBF + one year postpartum. by Larissa Brazolotto Ferreira (17671168)

Subjects:

General and sociodemographic characteristics of the EBF and EBF+ groups. by Larissa Brazolotto Ferreira (17671168)

Subjects: